Issue isn't just production it's mainly costs imo. They're running about double ipo estimates from my guesstimates.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025